In the 79 patients, majority (52, 65.8%) of the primary lesions showed high EGFR expression (2+/3+), compared to 46 (58.2%) in lymph node metastases. The gene discussed is EGFR; the disease is metastatic malignant neoplasm in the lymph nodes.